"Though many previous studies have reported antimicrobial activity of cinnamon essential oil, it is not widely used in the pharmaceutical industry," Topa said.
"We aimed to search for the molecular activity of this oil, focusing on its major component, cinnamaldehyde. This is the compound that gives cinnamon its flavour," she said.
Rather than killing the bacteria, Topa was looking to modify the behaviour of bacteria by disrupting bacterial communication to prevent biofilm formation.
"We hypothesised that using natural antimicrobials, such as essential oils, might interfere in biofilm formation. Thus, we focused on the impact of different concentrations of cinnamaldehyde in different biofilm development stages," Topa said.
She tested the effect of different concentrations of cinnamaldehyde on biofilms formed from the pathogenic Pseudomonas aeruginosa strain of bacteria.
Topa found that a sub-lethal concentration of cinnamaldehyde controlled the dispersion of Pseudomonas aeruginosa and the development of biofilm.
"Humans have a long history of using natural products to treat infections, and there is a renewed focus on such antimicrobial compounds. Natural products may offer a promising solution to this problem," Topa said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)